Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,375 0.28%
25 Jun - close price
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio:[1][2]
The company operates 4 hospitals across Thane, Pune, Indore & Dombivli with 1,248 operational beds (Census Beds and Non-Census Beds: 140).

Website BSE NSE
  • Market Cap ₹ 9,017 Cr.
  • Current Price ₹ 1,375
  • High / Low ₹ 1,625 / 1,152
  • Stock P/E 49.3
  • Book Value ₹ 245
  • Dividend Yield 0.07 %
  • ROCE 15.0 %
  • ROE 12.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 61.6% CAGR over last 5 years

Cons

  • Company has a low return on equity of 13.9% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
210 208 227 230 246 241 275 270 274 278 316 291 312
158 157 168 173 189 184 204 202 202 210 237 216 234
Operating Profit 52 51 59 57 57 57 71 69 72 68 79 76 78
OPM % 25% 25% 26% 25% 23% 24% 26% 25% 26% 24% 25% 26% 25%
4 5 5 8 10 7 7 7 7 13 11 4 10
Interest 7 8 9 1 1 1 1 3 4 3 3 3 4
Depreciation 7 8 8 8 7 8 10 11 13 17 17 17 18
Profit before tax 42 41 48 56 59 55 67 62 62 61 70 60 66
Tax % 36% 25% 25% 25% 27% 26% 25% 21% 28% 29% 23% 26% 25%
27 30 36 42 43 41 50 49 44 43 55 44 49
EPS in Rs 4.73 5.39 5.51 6.44 6.58 6.20 7.67 7.52 6.78 6.60 8.33 6.75 7.50
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
320 398 463 461 657 787 915 1,060 1,198
266 333 380 392 498 583 687 788 897
Operating Profit 54 65 83 69 159 204 227 272 300
OPM % 17% 16% 18% 15% 24% 26% 25% 26% 25%
5 2 2 4 4 11 26 25 38
Interest 16 24 26 28 29 28 19 9 13
Depreciation 20 24 26 27 28 29 31 42 69
Profit before tax 24 20 33 18 106 159 204 246 257
Tax % -25% 8% 10% 5% 20% 33% 25% 25% 25%
30 18 30 17 85 107 152 185 191
EPS in Rs 5.88 3.57 5.83 3.26 16.65 18.97 23.18 28.17 29.19
Dividend Payout % 8% 0% 0% 0% 0% 0% 4% 4% 3%
Compounded Sales Growth
10 Years: %
5 Years: 21%
3 Years: 15%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 62%
3 Years: 19%
TTM: 2%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -4%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 14%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 51 51 51 51 51 57 66 66 66
Reserves 147 162 186 202 278 409 1,180 1,357 1,542
210 252 263 262 322 298 0 142 335
63 71 94 100 104 123 115 153 218
Total Liabilities 470 537 594 615 755 885 1,361 1,718 2,160
379 431 435 426 465 476 477 713 1,123
CWIP 28 12 10 13 14 16 61 163 113
Investments 1 2 2 65 71 95 111 606 580
63 92 146 109 205 297 711 236 344
Total Assets 470 537 594 615 755 885 1,361 1,718 2,160

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
43 46 75 113 142 184 110 219 231
-43 -58 -43 -78 -68 -130 -238 -455 -423
1 16 -32 -23 10 -23 122 302 145
Net Cash Flow 1 3 -1 12 84 31 -6 66 -47
Free Cash Flow -4 -15 46 91 76 141 34 -62 -252
CFO/OP 100% 92% 109% 181% 95% 107% 70% 103% 97%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 20 24 35 16 15 19 18 13 20
Inventory Days 60 46 64 45 38 42 39 35 49
Days Payable 224 168 268 192 155 169 116 103 124
Cash Conversion Cycle -144 -98 -169 -132 -101 -108 -59 -56 -55
Working Capital Days 11 11 36 1 -18 -18 -7 -12 -12
ROCE % 10% 12% 9% 23% 27% 22% 18% 15%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
ALOS (Average Length of Stay)
Days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR
Average Occupancy Rate
%
Operational Bed Capacity
Number of Beds
Doctor Strength
Numbers
Inpatient Volume
Numbers
Outpatient (OPD) Volume
Numbers

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77% 9.06% 8.48% 8.48%
12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82% 16.97% 17.44% 17.01%
41.80% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51% 33.08% 33.17% 33.60%
No. of Shareholders 54,78239,34835,10735,79734,08133,91433,95634,19234,36133,62032,985

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls